about
Flexibility of the P-loop of Pim-1 kinase: observation of a novel conformation induced by interaction with an inhibitorA novel Pim-1 kinase inhibitor targeting residues that bind the substrate peptideA pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivoPredicting human liver microsomal stability with machine learning techniques.Application of support vector machine to three-dimensional shape-based virtual screening using comprehensive three-dimensional molecular shape overlay with known inhibitors.Insights from Pim1 structure for anti-cancer drug design.Prediction of ligand-induced structural polymorphism of receptor interaction sites using machine learning.An epoxidation mechanism of carbamazepine by CYP3A4.Identification of pyrrolo[2,3-d]pyrimidines as potent HCK and FLT3-ITD dual inhibitors.Theoretical Analysis of Activity Cliffs among Benzofuranone-Class Pim1 Inhibitors Using the Fragment Molecular Orbital Method with Molecular Mechanics Poisson-Boltzmann Surface Area (FMO+MM-PBSA) Approach.Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.Mechanism of the decrease in catalytic activity of human cytochrome P450 2C9 polymorphic variants investigated by computational analysis.Implementation of pi-pi interactions in molecular dynamics simulation.Identification of novel drug-resistant EGFR mutant inhibitors by in silico screening using comprehensive assessments of protein structures.Construction of an integrated database for hERG blocking small moleculesPrediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon CancerDiscovery of Novel Spiroindoline Derivatives as Selective Tankyrase InhibitorsSupport Vector Machine model for hERG inhibitory activities based on the integrated hERG database using descriptor selection by NSGA-II
P50
Q27671210-08DC2130-2F15-4C5F-82FA-CD8919B36922Q27677047-C1EB3998-6064-406A-97F7-B37D939C252BQ27684428-467CD314-66DF-48DE-879A-76FF3A98622BQ33293486-0AD632CA-2445-4970-857E-2DDA324A2C49Q34198159-4DE25A7D-0161-44BA-B7F1-B95DC5740AEFQ38045948-ABAF11E0-B907-4466-A413-F96B43BB6CA2Q45959736-9A861DFE-0730-4F77-B275-B1BDDBC645DDQ46677520-1DCBF7AF-B9B8-4D9B-A38A-DBC7EE2468E1Q47644817-464B70C7-800B-4F5B-9293-801A3900FCEAQ48049694-E8F2679B-7239-4986-ACA3-C2C261BE0DE3Q50916240-ACD8A926-15A4-423A-B4C2-C625848E766FQ51661467-0156DAA5-ABD3-4BD3-B932-14E94ED8429AQ51923446-AB27A9E3-B5E2-4B6C-9DB7-91BFEBBA5C38Q54510081-D5C3F791-B973-4119-990D-2A61A58540BDQ62674053-03799A06-5E2A-41AD-92A4-B8DD895BCFBAQ62674058-6D76EF16-7F24-496B-9530-F70037B32FACQ90587201-EBD58BFE-92EC-4343-893B-AC3DD4D0B8D6Q92440311-1A512B0F-9277-4361-9EA4-4B588341D968Q92757190-8704E998-DD4C-45A9-9732-B1E5D233784C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hitomi Yuki
@ast
Hitomi Yuki
@en
Hitomi Yuki
@es
Hitomi Yuki
@nl
Hitomi Yuki
@sl
type
label
Hitomi Yuki
@ast
Hitomi Yuki
@en
Hitomi Yuki
@es
Hitomi Yuki
@nl
Hitomi Yuki
@sl
prefLabel
Hitomi Yuki
@ast
Hitomi Yuki
@en
Hitomi Yuki
@es
Hitomi Yuki
@nl
Hitomi Yuki
@sl
P1053
C-5044-2012
P106
P1153
16070624200
P21
P31
P3829
P3835
hitomi-yuki
P496
0000-0002-8778-8261